Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACN vs GSK✓SelectedUSD · GSKACN vs GSK performance historyLatest closeAs of-4.93%11/18
Stock and ETF performance explorer

ACN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-33.0%
GSK return
+42.7%
Excess return
-75.7%
Maximum drawdown
-68.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.9%-1.3%-3.6%-4.6%
7D-10.3%-3.1%-7.2%-9.6%
30D-4.0%-0.9%-3.1%-3.8%
3M+32.6%-4.2%+36.8%+34.0%
6M+30.7%-1.6%+32.3%+31.4%
YTD-12.8%+2.6%-15.4%-13.9%
1Y-2.5%+6.2%-8.7%-4.7%
3Y-26.4%+55.0%-81.4%-36.3%
5Y-33.0%+42.8%-75.8%-46.4%
All-33.0%+42.7%-75.7%-46.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling